UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

 

biote Corp.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   85-1791125
(State of incorporation or organization)   (I.R.S. Employer Identification No.)

1875 W. Walnut Hill LN #100,

Irving, Texas

  75038
(Address of principal executive offices)   (Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class

to be so registered

  

Name of exchange on which
each class is to be registered

Class A common stock, $0.0001 par value per share    The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share    The Nasdaq Stock Market LLC

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box.  ☒

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box.  ☐

Securities Act registration statement file number to which the form relates:

333-265714 and 333-266433

Securities to be registered pursuant to Section 12(g) of the Act:

None

(Title of class)

 

 

 


Item 1.

Description of Registrant’s Securities to be Registered.

The securities to be registered hereby are the Class A common stock and warrants to purchase shares of Class A common stock of biote Corp. (the “Company”). The description of the Class A common stock and warrants contained in the section entitled “Description of Securities” in the prospectus included in the Company’s Registration Statements on Form S-1 (File Nos. 333-265714 and 333-266433) initially filed with the U.S. Securities and Exchange Commission on June 17, 2022 and August 1, 2022, respectively, as amended from time to time (the “Registration Statements”), to which this Form 8-A relates, is incorporated herein by reference. Any form of prospectus or prospectus supplement to the Registration Statement that includes such descriptions and that is subsequently filed is also incorporated by reference herein.

 

Item 2.

Exhibits.

Under the “Instructions as to Exhibits” with respect to Form 8-A, no exhibits are required to be filed with this registration statement because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.


SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

   

biote Corp.

Date: August 25, 2022     By:  

/s/ Teresa S. Weber

      Chief Executive Officer
Haymaker Acquisition Cor... (NASDAQ:HYACU)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Haymaker Acquisition Cor... Charts.
Haymaker Acquisition Cor... (NASDAQ:HYACU)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Haymaker Acquisition Cor... Charts.